Stock 7AL ALLIGATOR BIOSCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Alligator Bioscience AB Deutsche Boerse AG

Equities

7AL

SE0000767188

Delayed Deutsche Boerse AG
Other stock markets
 11:20:00 30/05/2024 pm IST 		5-day change 1st Jan Change
0.0784 EUR +2.35% Intraday chart for Alligator Bioscience AB +10.58% +38.52%
23/05 Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting CI
21/05 US FDA Grants Investigational New Drug Clearance for Alligator Bioscience's Late-stage Gastric Cancer Treatment Trial MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting
AQ
Alligator Bioscience : Announces Henlius Biotech has Received FDA IND Clearance for Phase 3 Initiation to Evaluate HLX22 (AC101) in 1st Line HER2+ Advanced Gastric Cancer
PU
Alligator Bioscience’s Announces Henlius Biotech has Received FDA IND Clearance for Phase 3 Initiation to Evaluate HLX22 (AC101) in 1st Line HER2+ Advanced Gastric Cancer
AQ
Alligator Bioscience : Announces Publication Highlighting Potential of Next Generation CD40 Agonists in Peer Reviewed Medical Journal "Expert Opinion on Biological Therapy"
PU
Alligator Bioscience Announces Publication Highlighting Potential of Next-Generation CD40 Agonists in Peer-Reviewed Medical Journal "Expert Opinion on Biological Therapy"
AQ
Alligator Bioscience Announces Initiation of an Investigator-Initiated Initiation of Phase 1 Clinical Study of Intratumoral Mitazalimab in Locally Advanced Pancreatic Cancer
AQ
Bulletin from the annual general meeting in Alligator Bioscience AB on 7 May 2024
AQ
Alligator Bioscience Q1 2024 - The Next Catalyst Will Be the 18-month Readout
AQ
Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update
AQ
BioStock: Orion option exercise triggers milestone payment for Alligator
AQ
Change in number of shares and votes in Alligator Bioscience AB
AQ
Alligator Bioscience and Orion Corporation announce exercise of development option under 2021 Immuno-oncology Research Collaboration and License Agreement
AQ
Last day of trading in paid subscribed units (Sw. BTU) in Alligator
AQ
Alligator publishes outcome in rights issue
AQ
Alligator Bioscience Announces Two Presentations on Mitazalimab and ATOR-4066 at the AACR Annual Meeting 2024
AQ
Notice of annual general meeting in Alligator Bioscience AB
AQ
BioStock: Alligator Bioscience on the importance of prolonging life
AQ
BioStock: Alligator to maximise immuno-oncology innovation
AQ
Alligator Bioscience Announces Publication Highlighting its RUBY® Bispecific Antibody Format in the Scientific Journal "mAbs"
AQ
Alligator publishes supplementary prospectus
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATORX Stock
  4. 7AL Stock
  5. News Alligator Bioscience AB
  6. Press Releases